The single use bioprocess system market refers to the market for disposable or single-use equipment and materials used in the production of biologic drugs, such as monoclonal antibodies, vaccines, and gene therapies. These systems are becoming increasingly popular in the bioprocessing industry due to their ability to reduce costs, improve efficiency and flexibility, and minimize cleaning and validation requirements. The market for single use bioprocess systems is expected to grow significantly in the coming years, driven by factors such as the increasing demand for biologic drugs, the growth of the biopharmaceutical industry, and advancements in technology.
The global single-use bioprocess systems market recorded a CAGR of 11.9% in the last six years from 2015 to 2021. Worldwide revenue from single-use bioprocess systems was US$ 5 Bn in 2021, with the market forecasted to surge ahead at a CAGR of 14.4% to reach a valuation of US$ 22.2 Bn by the end of 2032.
Request For Free Sample Report of “Single-Use Bioprocess Systems Market”@ https://www.persistencemarketresearch.com/samples/12142
One of the key drivers of the single-use bioprocess systems market is the increasing demand for biopharmaceuticals. As the global population continues to grow and age, there is a greater need for treatments for chronic diseases such as cancer, diabetes, and autoimmune disorders. Biopharmaceuticals, including monoclonal antibodies and protein-based drugs, are often used to treat these conditions and are in high demand.
Another factor driving the growth of the single-use bioprocess systems market is the adoption of flexible and scalable manufacturing processes. Traditional stainless steel equipment can be inflexible and costly to maintain, leading biomanufacturers to turn to single-use systems as a more efficient and cost-effective alternative. These systems can be easily scaled up or down to meet changing production needs, making them ideal for use in the development and production of new and innovative biopharmaceutical products.
- Thermo Fisher Scientific Inc.
- Sartorius Stedim Biotech
- Danaher Corporation
- Merck KGaA
- CESCO Bioengineering Co. Ltd.
- PBS Biotech, Inc.
- Distek, Inc.
- Eppendorf AG
- Celltainer Biotech B.V.
- Getinge (Applikon Biotechnology)
- Cellexus Ltd.
- Parker Hannifin Corp
- Mettler-Toledo International, Inc.
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/12142
Overall, the single-use bioprocess systems market is expected to experience significant growth in the coming years as the demand for biopharmaceuticals continues to rise and manufacturers seek out more efficient and cost-effective production methods.
To strengthen their market presence and expand their product lines in the global market, leading manufacturers are focussing on various market strategies such as mergers and acquisitions, expansion of their production facilities, and collaborations with various other companies to boost their sales of single-use bioprocess systems.
- Thermo Fisher Scientific Inc. launched the Thermo Scientific DynaSpin single-use centrifuge system on September 28, 2022, at the BioProcess International Annual Conference in Boston, Massachusetts, to provide the finest single-use option for mass cell culture harvesting.
- A contract extension with the U.S. Departments of Defence and Health & Human Services was announced by Corning on March 26, 2021.
- To advance its Vertical-Wheel single-use bioprocessing technology and cater to the need for cell treatment, PBS Biotech, a producer of single-use bioreactors, signed a private investment round with BroadOak Capital Partners for US$ 10 million.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/12142
- Cell Culture Bioreactors
- Fermentation Bioreactors
- Bioprocess Containers
- Transfer and Storage Bags
- Sampling Systems
- Filtration Systems
- Chromatography Columns
- Probes & Sensors
- Tubing Assemblies
- Connectors & Clamps
- Filling Systems
- Research & Development (R&D)
- GMP and Commercial Production
By End User:
- Biopharmaceutical Companies
- Contract Research Organizations
- Contract Manufacturing Organizations
- Research Institutes
Related Market Research Report:
Global Breast Implants Market report underlines factors influencing the growth of the industry along with a detailing of the key trends, drivers, restraints, opportunities & regulations.
Serum media is an often poorly defined cell culture medium. Depending on the source of serum, the composition of serum media may vary, which results in poor production and misinterpretation of results..
Global peripherally inserted central catheters market is projected to register a CAGR of 5.8% during the forecast period 2016 – 2024 in terms of value & revenue.
Global Human Papillomavirus Testing Market – check share, size, revenue, CAGR, regional outlook, key players, competitive landscape, top manufacturers & forecast.
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Persistence Market Research
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com